OFT to rule on key pathology mergers as another project collapses
Fresh evidence has emerged of the impact competition probes are having on plans to reconfigure services after Office of Fair Trading investigations were cited as barriers to two major pathology reorganisations.
You need to be signed in to read more
Subscribe for unlimited access
With a HSJ subscription you’ll unlock:
- All of HSJ.co.uk and our HSJ mobile app
- News and insight on all areas of public funded healthcare
- Expert commentary, insight and analysis from industry leaders
- 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics